Tuesday, 07 Apr 2020

You are here

Risk Factors for Pulmonary Hypertension in Lupus

Fidler and colleagues from Toronto have recently shown that pulmonary disease is common in lupus, as they found 56% of their patients with abnormal pulmonary assessments.  They found 12% with pleural disease, 11% with interstitial lung disease, 10% with shrinking lung syndrome and 5%  with pulmonary arterial hypertension (PAH).  (Citation source http://buff.ly/1SGqXVX)

Researchers from the Peking Union Medical College Hospital have studied PAH in systemic lupus erythematosus (SLE) using a case-control study design.  They identified 111 right-heart catherization confirmed SLE-PAH patients with a mean onset age of 34.6 years and an average lupus duration of 5 years. They found nearly half of patients were WHO Fc I-II, all were treated with immunosuppressants, and 65% took PAH-targeted therapy.

This study confirmed 2 independent risk factors for PAH that have been previously reported: A) pericardial effusion (OR = 21.290); and B) anti-RNP antibody (OR = 12.399).  They also identified 6 other independent variables that were significantly associated with PAH in SLE patients: 1) SLE duration; 2) interstitial lung disease; 3) not having an acute rash; 4) anti-SSA antibody; 5) SLEDAI ≤ 9; and 6) ESR≤20 mm/h and uric acid > 357 μmol/L. This study also showed that PAH-SLE patients usually diagnosed earlier have less disease severity than patients without PAH.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

In Lupus, Keep BP Below 130/80

Blood pressure should be maintained at a level below 130/80 mm Hg in all patients with lupus to lessen their likelihood of atherosclerotic vascular events, Canadian researchers asserted.

In Vasculitis, Beware of Infection

Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.

Malignancies with Giant Cell Arteritis

The Journal of Rheumatology reports the findings of a Swedish population-based cohort study of biopsy-proven giant cell arteritis (GCA) patients showing that the overall risk for cancer was not increased; yet there appears to be an increased risk for leukemia and a decreased risk for breast and upper gastrointestinal tract cancers.   

Hospitalized GPA - Higher morbidity, Mortality and Cost

Rheumatology reports on a study of patients with granulomatosis with polyangiitis (GPA) showing worse outcomes and higher costs when hospitalized with GPA.

GPA patients were identified from the Nationwide Inpatient Sample (NIS) and were compared to those without GPA with regard to demographics, procedures, length of stay, mortality, morbidity and total hospitalization charges (between 2005–2014).

Don't Blame the Weather in Sjogren's

Seasonal variations in symptoms -- commonly reported by patients with rheumatic diseases -- were not observed in a large cohort of patients with primary Sjogren's syndrome, French investigators found.